Navidea Biopharmaceuticals is a biopharmaceutical company engaged in developing and commercializing precision diagnostics and radiopharmaceutical agents. The company is actively developing four radiopharmaceutical agent platforms: Lymphoseek, NAV4694, NAV5001 and RIGScan. The company aims to deliver superior growth and shareholder return … Continue reading →

Eternity Healthcare is a leading medical technology company in the United States. The company’s state-of-the-art medical devices include diagnostic kits, digital cholesterol readers, injection-free needles and many others. The company’s products are sold throughout the world to consumers and to … Continue reading →

Antisense Therapeutics is an Australian pharmaceutical drug discovery and development company focused on creating, developing and commercializing novel antisense therapeutics. The company’s strategy involves creating antisense drugs – in collaboration with technology and research partners – that address diseases for … Continue reading →

Novavax is a global clinical-stage biopharmaceutical company engaged in creating vaccines to address a wide range of infectious diseases throughout the world. Using innovative technology and new efficient manufacturing approaches, Novavax produces potent vaccine candidates with the goal of enabling … Continue reading →

MDxHealth is a leading molecular diagnostics company focused on the development and commercialization of advanced epigenetic tests for cancer assessment and personalized patient treatment. The company applies its patented DNA methylation platform and biomarkers to help address a large and … Continue reading →

Oculus Innovative Sciences is a commercial healthcare company focused on designing, producing and marketing drugs, devices and nutritional products that are innovative, safe and effective. The company is engaged in pioneering innovative solutions in multiple markets, including dermatology, surgical, wound … Continue reading →

Biodel is a specialty pharmaceutical company that is engaged in the development and commercialization of innovative treatments for diabetes that are potentially safer, more effective and more convenient for diabetic patients. The company develops its product candidates by improving the … Continue reading →

Idera Pharmaceuticals is focused on applying its proprietary Toll-like receptor (TLR) drug discovery platform to create immunomodulatory drug candidates. The company has a clinical development program in autoimmune diseases as well as a collaboration with Merck & Co. for the … Continue reading →

VirtualScopics is a leader in providing quantitative imaging solutions that accelerate drug and medical device development. The company has developed a robust software platform for analyzing and modeling both structural and functional medical images. In combination with VirtualScopics’ industry-leading expertise … Continue reading →